Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

viatris limited - lenalidomide 25mg - capsule - 25 mg - active: lenalidomide 25mg excipient: colloidal silicon dioxide croscarmellose sodium gelatin   microcrystalline cellulose sodium stearyl fumarate starch tekprint black sw-9008 titanium dioxide   - multiple myeloma (mm) " the treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation. " the maintenance treatment of patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. " in combination with dexamethasone is indicated for the treatment of multiple myeloma patients whose disease has progressed after one therapy.

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

viatris limited - lenalidomide 5mg - capsule - 5 mg - active: lenalidomide 5mg excipient: colloidal silicon dioxide croscarmellose sodium gelatin   microcrystalline cellulose sodium stearyl fumarate starch tekprint black sw-9008 titanium dioxide   - multiple myeloma (mm) " the treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation. " the maintenance treatment of patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. " in combination with dexamethasone is indicated for the treatment of multiple myeloma patients whose disease has progressed after one therapy.

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

viatris limited - lenalidomide 7.5mg - capsule - 7.5 mg - active: lenalidomide 7.5mg excipient: colloidal silicon dioxide croscarmellose sodium gelatin   iron oxide black iron oxide yellow microcrystalline cellulose sodium stearyl fumarate starch tekprint black sw-9008 titanium dioxide   - multiple myeloma (mm) " the treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation. " the maintenance treatment of patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. " in combination with dexamethasone is indicated for the treatment of multiple myeloma patients whose disease has progressed after one therapy.

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

viatris limited - valsartan - film-coated tablet - angiotensin ii antagonists, plain; valsartan

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

viatris limited - valsartan - film-coated tablet - angiotensin ii antagonists, plain; valsartan

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

viatris limited - valsartan - film-coated tablet - angiotensin ii antagonists, plain; valsartan

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

viatris limited - valsartan - film-coated tablet - angiotensin ii antagonists, plain; valsartan

Malta - İngilizce - Medicines Authority

viatris limited damastown industrial park, mulhuddart, dublin 15, dublin, ireland - hard capsule - dabigatran etexilate 110 mg - antithrombotic agents

Malta - İngilizce - Medicines Authority

viatris limited damastown industrial park, mulhuddart, dublin 15, dublin, ireland - concentrate for solution for infusion - pemetrexed 25 mg/ml - antineoplastic agents

Malta - İngilizce - Medicines Authority

viatris limited damastown industrial park, mulhuddart, dublin 15, dublin, ireland - concentrate for solution for infusion - pemetrexed 25 mg/ml - antineoplastic agents